3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
2
Urinary Bladder Neoplasms
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Pancreatic Cancer Metastatic
1
Nasopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Renal Cell Carcinoma (RCC)
1
Advanced Malignant Solid Tumors
1
Advanced Lung Cancer
1
Advanced Breast Cancer
1
Interventions
durvalumab
2
Oxaliplatin
2
Leucovorin
2
Gemcitabine
2
Folfox protocol
2
Cisplatin
2
trastuzumab deruxtecan
1
tivozanib
1
guadecitabine
1
fludarabine
1
atezolizumab
1
Taxes
1
Specimen Handling
1
Platinum
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Irinotecan
1
Ipilimumab
1
Fluorouracil
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
toripalimab
×
30 days
×
Clear all
No trials found.